X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER CELL

期刊標題檢索 CANCER CELL 最新評論: Have you submitted your article for review? Mine has also been with th... (2024-08-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER CELL]您好,您是該頁面的第 110998 位訪客。

期刊簡介
期刊名稱CANCER CELL CANCER CELL
LetPub Score
9.8
50 ratings
Rate

Reputation
10.0

Influence
9.7

Speed
9.4

期刊簡稱CANCER CELL
ISSN1535-6108
E-ISSN1878-3686
h-index295
CiteScore
CiteScoreSJRSNIPCiteScore Rank
55.2017.5075.425
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q12 / 230
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q16 / 404

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.
官方網站http://www.cell.com/cancer-cell/home
在線稿件提交https://www.editorialmanager.com/CANCER-CELL
開放訪問No
出版商Cell Press
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2002
每年文章數120每年文章數趨勢
黃金OA百分比78.65%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ13/205
ONCOLOGYSCIEQ15/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-6108%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Extremely difficult
參考鏈接
相關期刊 【CANCER CELL】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330964
    CANCER RESEARCH312133
    BMC CANCER245501
    Asian Pacific Journal of Cancer Prevention219199
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191629
    CLINICAL CANCER RESEARCH181666
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176409
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
  •  

    CANCER CELL CANCER CELL
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CANCER CELL] 的評論撰寫評論
作者: 是靖香吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 22:28:36 評論於
Have you submitted your article for review? Mine has also been with the editor for a week.
(0) 讚! | 是靖香吖

作者: 大力玛丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-07 23:03:46 評論於
I have been with the editor for eighteen days.
(0) 讚! | 大力玛丽

作者: 雾都玉戈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-02 09:04:54 評論於
Have you submitted the Cancer Cell manuscript to the editor for review?
(0) 讚! | 雾都玉戈

作者: 碧桃古兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 13:30:26 評論於
All published in this magazine, dozens of articles a year, without any citations, it will be difficult to pursue a career in research
(0) 讚! | 碧桃古兰

作者: 茜54655


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-14 14:09:34 評論於
The bigshot Cell Press is from the United States
(0) 讚! | 茜54655

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-09 19:17:03 評論於
It's been almost 20 days with the editor, has anyone had the same experience? Should I send an email to inquire about it?
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 14:03:22 評論於
Hello, has the submission been sent for review after 20 days with the editor?
(0) 讚! | 西域妙绿

作者: 虚徒姗姗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 20:46:34 評論於
How long does it usually take?
(0) 讚! | 虚徒姗姗

作者: Martha Jacob


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-20 12:24:23 評論於
Is Cancer Cell a magazine from the United States?
(0) 讚! | Martha Jacob

作者: 北陆书意


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-16 17:52:05 評論於
Working with editor, may I ask what's next?
(0) 讚! | 北陆书意

作者: 西行寺雨安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-28 21:17:45 評論於
Congratulations! Could you please share the submission timeline?
(0) 讚! | 西行寺雨安

作者: 葵花辛巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 18:10:42 評論於
Research Focus: Oncology; Tumor Experience Sharing: The team's main efforts were focused on oncology immunology for three years, and finally published an article in the journal after facing numerous rejections in the past
(0) 讚! | 葵花辛巳

作者: 宗室思语


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-20 10:58:58 評論於
Hello, I wanted to ask if it's necessary to follow up on the status of my submission with the editor, as it has been 20 days since I submitted it
(0) 讚! | 宗室思语

作者: 血天谷云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-02 10:48:07 評論於
I was rejected for one application in 2018, and got a job offer in 2020. Recently, my productivity has been low. I only have one job at hand that I want to submit, but many things have been delayed due to the impact of the pandemic. I hope to finish it and submit it in the second half of the year
(0) 讚! | 血天谷云

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:35:01 評論於
I like reading books because they take me into different worlds and let me experience different lives. Reading is my way to relax and it also helps me learn a lot of knowledge
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:16:42 評論於
Make a list of the most important keywords; Come up with a title that encompasses all the vocabulary; Delete unnecessary/duplicate words and link the remaining words; Rewrite the title after deleting non-essential information
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 14:35:55 評論於
Is there a template for writing article titles?
(0) 讚! | 龙鳞孝礼

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 13:35:12 評論於
Is there a technique for writing article titles?
(0) 讚! | 北国博达

作者: 邻家飞跃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-07 12:24:55 評論於
Within a week
(0) 讚! | 邻家飞跃

作者: 暴风半松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-19 13:37:28 評論於
How long does it usually take to know whether the submission will be sent for review or rejected after the submission?
(0) 讚! | 暴风半松

作者: 邻家飞跃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-16 23:51:33 評論於
This journal is becoming increasingly difficult to submit to, focusing more on clinical research. It requires large-scale clinical data, which means that small laboratories are even less likely to publish in this journal. Strong financial backing is needed, and without it, it is difficult for non-experts to obtain such resources
(0) 讚! | 邻家飞跃

作者: 采南小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-15 22:55:31 評論於
Amazing
(0) 讚! | 采南小姐姐

作者: 血天谷云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-15 15:18:59 評論於
Participating in this has been a huge amount of work
(0) 讚! | 血天谷云

作者: 血天谷云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-10 12:12:06 評論於
To see if it is a big communication, is it the first unit?
(0) 讚! | 血天谷云

作者: 是友卉吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-11 18:28:48 評論於
Let's collaborate... maybe?
(0) 讚! | 是友卉吖

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CANCER CELL] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*